Назад
Company hidden
8 дней назад

Vice President, Strategy & Business Development - Advanced Therapeutics Division

280 000 - 481 250$
Формат работы
remote (только USA)/onsite
Тип работы
fulltime
Грейд
head
Английский
b2
Страна
US
Вакансия из списка Hirify.GlobalВакансия из Hirify Global, списка международных tech-компаний
Для мэтча и отклика нужен Plus

Мэтч & Сопровод

Для мэтча с этой вакансией нужен Plus

Описание вакансии

Текст:
/
TL;DR
Vice President, Strategy & Business Development - Advanced Therapeutics Division (CDMO/biopharma): Leading the growth, performance, portfolio strategy, commercial development, early R&D, capital allocation, and M&A agenda for a $600 million advanced therapeutics platform with an accent on RNA oligonucleotide manufacturing, biopharma partnerships, and enterprise P&L accountability. Focus on building predictable revenue pipelines, prioritizing technology and investment opportunities, integrating acquisitions, and aligning customer commitments with capacity, quality, delivery, and economics.

Location: Santa Clara, California, United States; remote work is available within the United States, with additional locations in Boston and Boulder.

Salary: $280,000–$481,250 per year, plus eligibility for bonus, stock, and benefits.

Company

hirify.global operates an advanced therapeutics CDMO platform spanning RNA oligonucleotide manufacturing and BioVectra, serving pharmaceutical and biotechnology customers from early development through commercial-scale manufacturing.

What you will do

  • Own the division’s P&L, revenue growth, profitability, margin expansion, cash generation, and return on invested capital.
  • Lead global business development from market development and lead generation through contracting, program awards, scale-up, and commercial handoff.
  • Build relationships with pharmaceutical and biotechnology decision-makers, strategic customers, technology partners, and scientific leaders.
  • Define portfolio strategy across RNA oligonucleotides, BioVectra, and adjacent advanced therapeutic modalities while overseeing early R&D and strategic marketing.
  • Direct capital allocation, acquisitions, partnerships, licensing, due diligence, and integration of acquired businesses.
  • Lead a geographically distributed, cross-functional organization across strategy, business development, R&D, marketing, operations, quality, regulatory, finance, HR, and legal.

Requirements

  • 15+ years of progressive leadership experience in CDMO, biopharma manufacturing, life-sciences tools or services, or a related sector.
  • Demonstrated responsibility for commercial growth and meaningful financial outcomes at scale; full P&L ownership is preferred.
  • Strong understanding of pharmaceutical and biotechnology customers and the scientific, regulatory, quality, and economic dynamics of development and manufacturing.
  • Experience with nucleic-acid therapeutics, oligonucleotides, RNA, biologics, APIs, peptides, complex chemistry, or other advanced therapeutic modalities.
  • Proven success in business development, strategic-account leadership, complex revenue pipelines, portfolio strategy, capital decisions, M&A, partnerships, and integration.
  • Bachelor’s degree in a relevant scientific, engineering, or business discipline required; an advanced degree is advantageous.

Nice to have

  • Direct oligonucleotide experience.
  • Full P&L or direct operations ownership.
  • Advanced scientific, engineering, or business degree.

Culture & Benefits

  • Full-time position with the option to work remotely within the United States.
  • Occasional travel is required.
  • Day shift with no stated end date.
  • Bonus, stock, and benefits eligibility.
  • Leadership culture centered on customer focus, accountability, collaboration, scientific curiosity, continuous improvement, and talent development.

Будьте осторожны: если работодатель просит войти в их систему, используя iCloud/Google, прислать код/пароль, запустить код/ПО, не делайте этого - это мошенники. Обязательно жмите "Пожаловаться" или пишите в поддержку. Подробнее в гайде →